9-chloro-prostaglandin derivatives
US5756818A · kind A · utility
18Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 29, 1996 |
| Grant date | May 26, 1998 |
| Priority date | — |
| Expiry date | May 29, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C405/0025
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to 9-chloro-prostaglandin derivatives of formula I ##STR1## in which X means oxygen or CH.sub.2, PA1 R.sup.1 means hydrogen or straight-chain or branched alkyl with 1-6 C atoms and PA1 A means trans-CH.dbd.CH-- or --CH.sub.2 --CH.sub.2 --, as well as their salts with physiologically compatible bases, if R.sup.1 represents hydrogen, and their clathrates with .alpha.-, .beta.- or .gamma.-cyclodextrin, process for their production and their pharmaceutical use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.